1-12 of 12
M. Attal
Close
Sort by
Journal Articles

Major Superiority of Melphalan - Prednisone (MP) + Thalidomide (THAL) over MP and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients with Multiple Myeloma.

Thierry Facon, J.Y. Mary, C. Hulin, L. Benboubker, M. Attal, M. Renaud, J.L. Harousseau, B. Pegourie, G. Guillerm, C. Chaleteix, M. Dib, L. Voillat, H. Maisonneuve, J. Troncy, V. Dorvaux, M. Monconduit, C. Martin, P. Casassus, J. Jaubert, H. Jardel, B. Kolb, F. Bauters
Journal: Blood
Blood (2005) 106 (11): 780.
https://doi.org/10.1182/blood.V106.11.780.780
Published: 2005
Journal Articles

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

L Sutton, C Chastang, P Ribaud, JP Jouet, M Kuentz, M Attal, J Reiffers, JM Tigaud, B Rio, C Dauriac, M Legros, F Dreyfus, B Lioure, X Troussard, N Milpied, F Witz, P Oriol, JY Cahn, M Michallet, E Gluckman, N Ifrah, JL Pico, E Vilmer, V Leblond
Journal: Blood
Blood (1996) 88 (1): 358–365.
https://doi.org/10.1182/blood.V88.1.358.358
Published: 1996
Journal Articles

Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group

M Attal, D Blaise, G Marit, C Payen, M Michallet, JP Vernant, C Sauvage, X Troussard, G Nedellec, J Pico
Journal: Blood
Blood (1995) 86 (4): 1619–1628.
https://doi.org/10.1182/blood.V86.4.1619.bloodjournal8641619
Published: 1995
Journal Articles

Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma

JL Harousseau, M Attal, M Divine, G Marit, V Leblond, AM Stoppa, JH Bourhis, D Caillot, M Boasson, JF Abgrall
Journal: Blood
Blood (1995) 85 (11): 3077–3085.
https://doi.org/10.1182/blood.V85.11.3077.bloodjournal85113077
Published: 1995
Journal Articles

Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)

A Devergie, D Blaise, M Attal, JD Tigaud, JP Jouet, JP Vernant, P Bordigoni, N Ifrah, C Dauriac, JY Cahn
Journal: Blood
Blood (1995) 85 (8): 2263–2268.
https://doi.org/10.1182/blood.V85.8.2263.bloodjournal8582263
Published: 1995
Journal Articles

Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial

M Attal, F Huguet, H Rubie, JP Charlet, D Schlaifer, A Huynh, G Laurent, J Pris
Journal: Blood
Blood (1993) 82 (3): 732–736.
https://doi.org/10.1182/blood.V82.3.732.732
Published: 1993
Journal Articles

Myeloperoxidase: an enzyme involved in intrinsic vincristine resistance in human myeloblastic leukemia

D Schlaifer, MR Cooper, M Attal, AO Sartor, JB Trepel, G Laurent, CE Myers
Journal: Blood
Blood (1993) 81 (2): 482–489.
https://doi.org/10.1182/blood.V81.2.482.482
Published: 1993
Journal Articles

Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see comments]

M Attal, F Huguet, H Rubie, A Huynh, JP Charlet, JL Payen, JJ Voigt, P Brousset, J Selves, C Muller
Journal: Blood
Blood (1992) 79 (11): 2834–2840.
https://doi.org/10.1182/blood.V79.11.2834.2834
Published: 1992
Journal Articles

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

D Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergie, JP Jouet, N Milpied, M Attal, M Michallet, N Ifrah
Journal: Blood
Blood (1992) 79 (10): 2578–2582.
https://doi.org/10.1182/blood.V79.10.2578.2578
Published: 1992
Journal Articles

Intensive combined therapy for previously untreated aggressive myeloma

M Attal, F Huguet, D Schlaifer, C Payen, M Laroche, B Fournie, B Mazieres, J Pris, G Laurent
Journal: Blood
Blood (1992) 79 (5): 1130–1136.
https://doi.org/10.1182/blood.V79.5.1130.1130
Published: 1992
Journal Articles

Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation

D Blaise, D Olive, AM Stoppa, P Viens, C Pourreau, M Lopez, M Attal, C Jasmin, G Monges, C Mawas
Journal: Blood
Blood (1990) 76 (6): 1092–1097.
https://doi.org/10.1182/blood.V76.6.1092.1092
Published: 1990
Journal Articles

t(14;14)(q11;q32) in biphenotypic blastic phase of chronic myeloid leukemia

N Dastugue, E Kuhlein, E Duchayne, F Roubinet, G Bourrouillou, M Attal, J Pris, P Colombies
Journal: Blood
Blood (1986) 68 (4): 949–953.
https://doi.org/10.1182/blood.V68.4.949.949
Published: 1986